A recent analysis of roughly 800 global seed financings closed this year shows that mid-sized seed rounds — deals of $5 million to $10 million — are concentrating in a handful of established but active sectors: proptech, cancer therapeutics, space and satellite technology, and robotics. The exercise aimed to highlight where classic, higher-risk seed bets are being placed in an investment climate increasingly dominated by very large financings.
Where $5M–$10M seed rounds are clustering
This $5M–$10M band was chosen to capture rounds more representative of the traditional seed stage — modestly funded teams pursuing unproven founders, technologies or business models. Across the sample, several recurring themes emerged, revealing the types of problems investors appear willing to back with midsize early cheques.
Proptech: efficiency, decarbonization and operations
Real estate’s sheer scale — once estimated to represent about two‑thirds of global net worth — helps explain investor interest. Although venture capital tied to property and construction remains small relative to the asset class (last year investment in proptech totaled just over $10 billion), seed investors are funding startups that aim to streamline planning and building, improve rental operations and cut building energy use. In the sample set of 15 proptech seed rounds in the $5M–$10M range, notable names include Hint (an AI-powered home management system), Optiml (software for real estate decarbonization) and Krane (an AI-enabled construction supply chain platform).
Cancer therapeutics: early bets on long‑term impact
Invest
